消痹方联合关节镜清理术治疗肝肾亏虚型膝骨关节炎临床研究

Clinical Study on Xiaobi Prescription Combined with Arthroscopic Debridement for Knee Osteoarthritis of Liver-Kidney Deficiency Type

目的:观察消痹方联合关节镜清理术治疗肝肾亏虚型膝骨关节炎的疗效。方法:选取80例肝肾亏虚型膝骨关节炎患者,按随机数字表法分为观察组与对照组各40例。对照组给予膝关节镜清理术治疗,同时给予常规药物止痛及康复训练;观察组在对照组基础上加服消痹方。观察2组临床疗效及安全性,比较2组术前术后1、2个月的Lysholm膝关节功能评分、疼痛视觉模拟评分法(VAS)评分的变化。结果:术后1个月、术后2个月,2组Lysholm膝关节功能评分均较术前升高,观察组Lysholm膝关节功能评分均高于同一时间段对照组,差异均有统计学意义(P<0.05)。术后1个月、术后2个月,2组VAS评分均较术前降低,观察组VAS评分均低于同一时间段对照组,差异均有统计学意义(P<0.05)。术后,观察组临床疗效总有效率为95%,对照组为90%,2组比较,差异有统计学意义(P<0.05)。术后,2组治疗安全性比较,差异无统计学意义(P>0.05)。结论:关节镜清理术联合消痹方治疗肝肾亏虚型膝骨关节炎的疗效较好,可提高术后膝关节功能,缓解关节疼痛。

Objective:To observe the curative effect of Xiaobi prescription combined with arthroscopic debridement on knee osteoarthritis of liver-kidney deficiency type. Methods:A total of 80 cases of patients with knee osteoarthritis were selected and divided into the observation group and the control group according to the random number table method,with 40 cases in each group. The control group was treated with arthroscopic debridement, routine medicine for analgesia and rehabilitation training, and the observation group was additionally treated with Xiaobi prescription based on the treatment of the control group. The clinical effects and safety in the two groups were observed. Before arthroscopic debridement and one and two months after arthroscopic debridement, the changes of Lysholm scores for knee joint function and Visual Analogue Scale(VAS) scores for pain were compared between the two groups. Results:One and two months after arthroscopic debridement,the Lysholm scores for knee joint function in the two groups were increased when compared with those before arthroscopic debridement,and the above score in the observation group was higher than that in the control group at the same time respectively,differences being significant(P<0.05). One and two months after arthroscopic debridement,the Lysholm scores for knee joint function in the two groups were increased when compared with those before arthroscopic debridement,and the above score in the observation group was higher than that in the control group at the same time respectively,differences being significant(P<0.05). After arthroscopic debridement,the total clinical effective rate was 95% in the observation group and 90% in the control group, the difference being significant(P<0.05). After arthroscopic debridement,there was no significant difference being found in the comparison of treatment safety between the two groups(P>0.05). Conclusion: The therapy of Xiaobi prescription combined with arthroscopic debridement has a good curative effect on knee osteoarthritis of liver-kidney deficiency type,which can improve the knee joint function after arthroscopic debridement and relieve the pain in knee joint.